Researchers Pursue Multiple Approaches to Curing and Controlling Type 1 Diabetes

Researchers are following multiple strategies to preventing, treating and possibly even curing type 1 diabetes which affects 1 to 2 million people in the U.S. and millions more worldwide. In this country, it is second only to asthma as the most common chronic disease in children. This is an exciting time for finding a cure.

Type 1 diabetes may begin at any age, when for yet-unknown reasons, a person’s immune system mistakenly attacks beta cells that produce insulin. Patients with this type of diabetes are dependent for life on insulin injections or insulin medications.
The Children’s Hospital of Philadelphia has set for itself the ambitious goal of advancing pediatric care worldwide, by testing different methods to help those with Type 1 diabetes.

Gene Discovery Helps Reveal Treatment Targets on Diabetes Pathways: Because all types of diabetes are complex diseases, affected by interactions among multiple genes, genomics researchers focus on identifying all the genes involved, as a foundation for further investigating how genes function on biological pathways that lead to diabetes. At the Children’s Hospital’s Center for Applied Genomics, the world’s largest pediatric genotyping project, a study team in July 2007 identified a previously unknown gene variant that raises a child’s risk of type 1 diabetes. Using highly automated DNA scanners, the researchers have since discovered and confirmed other gene variants, and will augment the list with other findings in the coming months. Hakon Hakonarson, M.D., the center’s director, says “better understanding of these gene pathways may shed light on ways to intervene early in life with targeted drugs or cell therapies that could prevent diabetes from developing." (Center for Applied Genomics:

Findings on Beta Cells May Enable Body to Restore Insulin Production: Because the basic problem in type 1 diabetes is the body’s lack of insulin, pediatric endocrinologist Jake Kushner, M.D., searched for adult stem cells thought to develop into the beta cells that secrete insulin in the pancreas. But those adult stem cells weren’t there. Instead, in his animal studies, he found that beta cells themselves divided slowly to produce new beta cells after a prolonged delay never previously seen in mammals. Although most beta cells fall victim to the body’s immune system in type 1 diabetes, Kushner says that learning how to manipulate the beta cells’ development could make them replicate faster and outpace the disease. His approach dovetails with beta cell regeneration, a controversial area of diabetes research. In 2001, Boston researchers discovered that residual numbers of beta cells escape autoimmune destruction even in patients with longstanding type 1 diabetes. With deeper knowledge and better techniques, Kushner suggests that scientists might eventually stimulate patients’ own residual beta cells to proliferate and produce therapeutic amounts of insulin. More about Dr. Kushner’s research:

Screening and Insulin Pill May Prevent Type 1 Diabetes in Those at Risk:Children’s Hospital is taking part in Type 1 Diabetes TrialNet, a worldwide consortium of research centers dedicated to delaying or preventing the onset of type 1 diabetes in children and adults. Under TrialNet, centers perform blood tests on children and adults who are at higher risk for type 1 diabetes because a close family member (first- or second-degree) has the disease. If the blood test detects autoantibodies to diabetes that may appear years before type 1 diabetes develops, the patient may enter a study of a new medical intervention that uses oral insulin. A preliminary study indicated that oral insulin may delay or prevent type 1 diabetes among some people found to be at risk of the disease. Children’s Hospital is among 150 medical centers on three continents participating in Type 1 Diabetes TrialNet, sponsored by the National Institutes of Health. Lorraine Levitt Katz, M.D., a pediatric endocrinologist at the Hospital’s Diabetes Center for Children, leads the study. (Web page for the Diabetes Center for Children Click here

See this week’s Special Feature from TrialNet TrialNet FEATURE

====================================================

Advertisement

You’ve probably heard the term "low glycemic" bandied about in the media and in discussions about weight loss. You may have even come across some food products labeled as such.

It’s All About Sugar

"Glycemic" simply means "relating to sugar." The higher the glycemic impact of a food the greater and more rapid its effect on your blood sugar when you eat it. High blood sugar can sabotage your weight-management and better health efforts. Eating lower glycemic foods is definitely the way to go.

Atkins Advantage(r) nutrition bars and shakes are low-glycemic impact and substantiated by clinical testing. A controlled carbohydrate, low sugar way of eating provides you with a powerhouse of nutrients to support your health and stabilized blood-sugar levels. Click here for more information